Cost-effectiveness of using angiotensin-converting enzyme inhibitors to slow nephropathy in normotensive patients with diabetes type II and microalbuminuria

Nephrology

Volumn 6, Issue 2, 2001, Pages 71-77

  Sakthong, Phantipa ^a,b,c,d   Tangphao, Oranee ^a,b,c,d,g,h   Eiam Ong, Somchai ^a,b,f,g,h   Kamolratanakul, Pirom ^a,f,g,h   Supakankunti, Siripen ^a,e,f,g,h   Himathongkam, Thep ^a,e,f,g,h   Yathavong, Kitima ^a,b,f,g,h  

^a Faculty of Science   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

^c Division of Nephrology   (Thailand)

^d CHULALONGKORN UNIVERSITY   (Thailand)

^e CHULALONGKORN UNIVERSITY   (Thailand)

^f Theptarin Hospital   (Thailand)

^g Chulalongkorn University Hospital Bangkok ^*  (Thailand)

^h KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

ACE inhibitors; Cost effectiveness; Diabetic nephropathy; Incremental cost effectiveness ratio (ICER); Microalbuminuria

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIABETIC NEPHROPATHY; DRUG COST; HEMODIALYSIS; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION; PRIORITY JOURNAL; PROBABILITY;

EID: 0035047349     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1797.2001.00036.x     Document Type: Article

References (35)

1. The natural history of diabetic nephropathy
2. Diabetic nephropathy in type 1 (insulin dependent) diabetes: An epidemiological study
3. Incidence and prevalence of ESRD
4. The economic cost of ESRD and Medicare spending for alternative modalities of treatment
5. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy
6. Efficacy of captopril in normotensive diabetic patients with microalbuminuria-8 years follow up
7. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria
8. Randomized placebo control trial of lisinopril in normotensive patients and insulin-dependent diabetes with normoalbuminuria or microalbuminuria
9. Long-term effect of ACE inhibition on development of nephropathy in diabetes mellitus type II
10. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus: A 7-year follow-up study
11. Use of enalapril to attenuate the decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus: A randomized, controlled trial
12. Lessons from clinical trials in diabetic patients: Angiotensin converting enzyme inhibitors in diabetic patients with microalbuminuria or normoalbuminuria
13. Effects of long-term enalapril treatment on persistent microalbuminuria in well-controlled hypertensive and normotensive NIDDM patients
14. Effect of low-dose ramipril on microalbuminuria in normotensive or mildly hypertensive non-insulin dependent diabetic patients
15. Effective postponement of diabetic Nephropathy with enalapril in Normotensive type 2 diabetic patients with microalbuminuria
16. Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus
17. Modeling and costing the consequences of using an ACE-Inhibitor to slow the progression of renal failure in type 1 diabetic patients
18. Routine treatment of insulin-dependent diabetic patients with ACE inhibitors to prevent renal failure: An economic evaluation
19. An economic analysis of captopril in the treatment of diabetic nephropathy
20. An Introduction to Markov modelling for economic evaluation
21. Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria
22. Chronic hemodialysis in Pramongkutklao Hospital: A 14-year experience
23. Foundations of cost-effectiveness analysis for health and medical practices
24. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
25. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
26. Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis
27. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
28. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial
29. Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?
30. The effect of nisoldipine as compared with enalapril on cardiovascular events in patients with non-insulin-dependent diabetes and hypertension
31. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM